Primary Record
piroxicam
- In stock
- 7,826 g
- Purity
- 99.4 %
- CAS
- 36322-90-4
Compound Identifiers & Properties
- CAS
- 36322-90-4
- PubChem CID
- 54676228
- SMILES
- CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3
- Canonical SMILES
- CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O
Names & Synonyms
- piroxicam
- Feldene
- Piroxicamum
- Pyroxycam
- 36322-90-4
- Roxicam
- Piroftal
- BAXO
- Artroxicam
- Larapam
- Flogobene
- Improntal
- Bruxicam
- Caliment
- Piroflex
- Solocalm
- Geldene
- Reudene
- Roxiden
- Sasulen
- Erazon
- Pirkam
- Riacen
- Zunden
- piroxicam usp
- Roxam
- lidocaine
- Brexidol
- Pipoxicam
- Rosiden
- Felden
- Piroxicam betadex
- Akten
- Apo-Piroxicam
- Feldene Fast
- Feldene Gel
- Brexicam
- Cicladol
- Flamatrol
- Piroxicam-d3
- Kentene
- Brexin
- Flamatrol;
- Improntal;
- Roxam;Feldene
- Cycladol;
- Feldene p
- Piroflam;
- Larapam;
- Pirozip;
- Reudene;
- Piroxicam olamine
- Brexin;
- Piroxicam CRS
- Feldene (TN)
- Fasax;
- Pirox;
- Piroxicam (Feldene)
- Piroxicamum [INN-Latin]
- Piroflam 10
- Piroflam 20
- Brexidol (TN)
- Feldoral (TN)
- Proponol (TN)
- Reumador (TN)
- Feldene 20
- Pirozip 10
- Pirozip 20
- Prestwick_573
- Hotemin (TN)
- Mobilis (TN)
- Brexin (TN)
- Erazon (TN)
- Exipan (TN)
- Felden (TN)
- Tracam (TN)
- Vurdon (TN)
- C15H13N3O4S
- CP-16171
- Piroxicam (Standard)
- Veral (TN)
- piroxicam:malonic acid
- Ampicillin sodium salt
- Pirox von ct (TN)
- 13T4O6VMAM
- RefChem:6147
- CHF 1251
- Spectrum_001115
- Tocris-0960
- Piroxicam-(methyl-d3)
- Opera_ID_442
- PIROXICAM [INN]
- PIROXICAM [JAN]
- Piroxicam: Form Alpha1
- Piroxicam: Form Alpha2
- UNII-13T4O6VMAM
- DTXSID5021170
- PIROXICAM [MI]
- AC1NQX1P
- AC1NSM2R
- AC1Q3XLJ
- CP 16171
- PIROXICAM [USAN]
- Prestwick0_000211
- Prestwick1_000211
- Prestwick2_000211
- Prestwick3_000211
- Spectrum2_001287
- Spectrum3_000780
- Spectrum4_000968
- Spectrum5_001445
- CCRIS 3719
- CHEBI:8249
- Lopac-P-5654
- PIROXICAM [VANDF]
- PIROXICAM ANHYDROUS
- QYSPLQLAKJAUJT-UHFFFAOYSA-N
- piroxicam beta-cyclodextrin
- Feldene, Roxam, Piroxicam
- CHEMBL527
- D00IBN
- Epitope ID:613453
- PIROXICAM [MART.]
- AC1L1J3Z
- MLS000069644
- PIROXICAM [USP-RS]
- PIROXICAM [WHO-DD]
- DTXCID401170
- Piroxicam [USAN:BAN:INN:JAN]
- BIDD:PXR0154
- Lopac0_000900
- MFCD00057317
- Oprea1_714707
- Piroxicam for system suitability
- SCHEMBL13462
- SCHEMBL21350
- BSPBio_000221
- BSPBio_001030
- BSPBio_002460
- KBioGR_000370
- KBioGR_001315
- KBioSS_000370
- KBioSS_001595
- MLS000038002
- MLS001148207
- MLS001304054
- MLS004774122
- DivK1c_000369
- NSC 666076
- NSC-666076
- SPECTRUM1500491
- 4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide
- CP16171
- EINECS 252-974-3
- SPBio_001293
- SPBio_002142
- AK1015
- NSC666076
- Piroxicam (JP15/USP/INN)
- Piroxicam (JP18/USP/INN)
- Piroxicam D3 (N-methyl D3)
- BPBio1_000245
- GTPL7273
- orb1310318
- Piroxicam, >=98% (TLC)
- SCHEMBL3703617
- PIROXICAM [ORANGE BOOK]
- CHEMBL1518938
- PIROXICAM [EP MONOGRAPH]
- SCHEMBL29352427
- SCHEMBL29396075
- BCBcMAP01_000176
- BDBM85245
- CTK7I2700
- ERK5-2A11
- HMS501C11
- HY-B0253R
- KBio1_000369
- KBio2_000370
- KBio2_001595
- KBio2_002938
- KBio2_004163
- KBio2_005506
- KBio2_006731
- KBio3_000719
- KBio3_000720
- KBio3_001680
- KS-00000JBT
- BRN 0627692
- CID4856
- CP-16,171
- M01AC01
- M02AA07
- MSK7162
- PIROXICAM [USP MONOGRAPH]
- S01BC06
- NINDS_000369
- Piroxicam [USAN:INN:BAN:JAN]
- Piroxicam 1.0 mg/ml in Methanol
- Piroxicam CRS (P2130000)
- Bio1_000363
- Bio1_000852
- Bio1_001341
- Bio2_000355
- Bio2_000835
- GLXC-26155
- GLXC-26156
- HMS1362D11
- HMS1568L03
- HMS1792D11
- HMS1920H22
- HMS1990D11
- HMS2089B06
- HMS2092A05
- HMS2095L03
- HMS2231G03
- HMS3262D22
- HMS3267I03
- HMS3369B07
- HMS3403D11
- HMS3414H17
- HMS3429L03
- HMS3655C04
- HMS3678H15
- HMS3712L03
- HMS3884C08
- HMS5079F16
- Pharmakon1600-01500491
- Piroxicam-beta-cyclodextrin complex
- 2,3,4,5,6-Pentafluorothiophenol
- Piroxicam [USAN:USP:INN:BAN:JAN]
- 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide
- BCP02919
- HY-B0253
- NSC_4856
- Tox21_110231
- Tox21_200151
- Tox21_500900
- ANW-43611
- C15-H13-N3-O4-S
- CCG-36403
- EBC-11158
- EBC-26614
- MSK7162-100A
- NCGC00015823-02
- NSC757284
- Piroxicam for system suitability CRS
- s1713
- STK177288
- ZINC12466469
- ZINC51133897
- ZINC87724780
- SMR000035997
- AKOS000714958
- AKOS025312555
- AKOS026749939
- MSK7162-1000A
- Tox21_110231_1
- ACN-048770
- AM84917
- CID5280452
- CID5312135
- CS-2233
- CS-W-00225
- DB00554
- FP27085
- KS-5322
- LP00900
- LS-7663
- NSC-757284
- SDCCGSBI-0050875.P005
- CAS-36322-90-4
- IDI1_000369
- IDI1_002110
- NCGC00015823-01
- NCGC00015823-03
- NCGC00015823-04
- NCGC00015823-05
- NCGC00015823-06
- NCGC00015823-07
- NCGC00015823-08
- NCGC00015823-09
- NCGC00015823-10
- NCGC00015823-11
- NCGC00015823-12
- NCGC00015823-13
- NCGC00015823-14
- NCGC00015823-15
- NCGC00015823-17
- NCGC00015823-18
- NCGC00015823-20
- NCGC00015823-29
- NCGC00021244-03
- NCGC00021244-05
- NCGC00021244-06
- NCGC00021244-07
- NCGC00021244-08
- NCGC00021244-09
- NCGC00188982-01
- NCGC00257705-01
- NCGC00261585-01
- AC-24190
- BAS 04381594
- BC204217
- CID:54676228
- NCI60_022912
- SC-16825
- SID:53787088
- ST069379
- BCP0726000299
- P 5654
- SBI-0050875.P004
- AB0011706
- AB2000240
- AJ-111664
- CAS_36322-90-4
- Piroxicam, meets USP testing specifications
- ST2411449
- TR-014899
- A8503
- EU-0100900
- FT-0630590
- FT-0673949
- NS00015466
- P1905
- SW219862-1
- 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid
- 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
- EN300-70724
- Piroxicam Solution in Acetonitrile, 100ug/mL
- A10736
- A19556
- C01608
- D00127
- D70554
- J10253
- M-9898
- Piroxicam Solution in Acetonitrile, 1000ug/mL
- 4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide
- 4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- AB00052074-21
- AB00052074-22
- AB00052074_23
- AB00052074_24
- 322P904
- D010894
- F340495
- Q408676
- SR-01000000199
- 1044566-76-8
- 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- A1202297
- Piroxicam for system suitability CRS (Y0001475)
- SR-01000000199-3
- SR-01000000199-5
- SR-01000000199-9
- 2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide
- 4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide
- 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German]
- 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- 4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- SR-01000000199-12
- F0001-2399
- Piroxicam, British Pharmacopoeia (BP) Reference Standard
- Z1137167677
- 3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1
- Piroxicam, 98%, a non-selective COX inhibitor - 10G 10g
- Piroxicam, European Pharmacopoeia (EP) Reference Standard
- (3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1
- (3Z)-3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione
- 4-Hydroxy-2-methyl-3[pyrid-2-yl-carbamoyl]-2H-1,2-benzothiazine 1,1-dioxide
- Piroxicam, United States Pharmacopeia (USP) Reference Standard
- (4-hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e
- (4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide
- 3,4-Dihydro-2-methyl-4-oxo-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- 3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1
- 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
- 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
- (3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1
- (Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2H-benzo[e][1,2]thiazin-4(3H)-one 1,1-dioxide
- 137-58-6
- 942047-64-5
- Piroxicam, Pharmaceutical Secondary Standard; Certified Reference Material
- 2-methyl-N-(pyridin-2-yl)-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- 4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide
- 4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1lambda6,2-benzothiazine-3-carboxamide
- 4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l^(6),2-benzothiazine-3-carboxamide
- 4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l^{6},2-benzothiazine-3-carboxamide
- 4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide
- 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzo-thiazine-3-carboxamide1,1-dioxide
- 4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide1,1-dioxide
- 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide
- 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboximide-1,1-dioxide
- 4-Hydroxy-3-(pyridin-2-yl-carbamoyl)-2-methyl-2H-1,2-benzothiazin-1,1-dioxide
- N-(2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- (E)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2,3-dihydro-4H-benzo[e][1,2]thiazin-4-one 1,1-dioxide
- 252-974-3
- 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; Artroxicam; Baxo; Bruxicam; CHF 1251; CP 16171; Caliment; Dispercam; Doblexan; Dolibid; Erazon; Felden gel; Feldene; Feldene Melt; Feloxin; Felvin 20; Felxicam; Flogobene; Geldene; Improntal; Larapam; Laxidene; Maxvin; NSC 666076; Neoxicam; Nkoyo piroxicam; Pirkam; Piroflex; Piroftal; Piroxicam; Piroxidine; Pixicam; Pyroxycam; Reudene; Rheugesic; Riacen; Roxicam; Roxiden; Sasulen; Solocalm; Uphaxicam; Zunden; Zydis; Feldene Zydis; Feldoral; Feledene; Flogosan; Murupe; Nesprex-DT; Piroxitas-DT
- 3-(Hydroxy[(pyridin-2-yl)amino]methylidene)-2-methyl-3,4-dihydro-2h-1lambda(6),2-benzothiazine-1,1,4-trione
- 3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-2,3-dihydro-4h-1,2-benzothiazin-4-one 1,1-dioxide
- 3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione
- 3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione
- 3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione
- 4-Hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-1,2-dihydro-1lambda~6~,2-benzothiazine-3-carboxamide
- 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine -3-carboxamide-1,1-dioxide malonic acid
- 69-52-3
- Sodium (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate